Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mimedx (MDXG) Income from Continuing Operations (2016 - 2026)

Mimedx's Income from Continuing Operations history spans 16 years, with the latest figure at 10860000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 254.63% to 10860000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 30697000.0, a 23.18% decrease, with the full-year FY2025 number at 48578000.0, up 15.67% from a year prior.
  • Income from Continuing Operations hit 10860000.0 in Q1 2026 for Mimedx, down from 15191000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for MDXG hit a ceiling of 51288000.0 in Q4 2023 and a floor of 10868000.0 in Q2 2022.
  • Historically, Income from Continuing Operations has averaged 7482588.24 across 5 years, with a median of 8842000.0 in 2023.
  • The widest YoY moves for Income from Continuing Operations: up 4839.7% in 2022, down 510.91% in 2022.
  • Tracing MDXG's Income from Continuing Operations over 5 years: stood at 9830000.0 in 2022, then soared by 421.75% to 51288000.0 in 2023, then plummeted by 85.5% to 7438000.0 in 2024, then soared by 104.24% to 15191000.0 in 2025, then plummeted by 171.49% to 10860000.0 in 2026.
  • Business Quant data shows Income from Continuing Operations for MDXG at 10860000.0 in Q1 2026, 15191000.0 in Q4 2025, and 16748000.0 in Q3 2025.